Inventor · disambiguated record
Reetobrata Basu
Also filed as: BASU REETOBRATA
8 granted patents·3 pending applications·1 citations·filing 2017–2024
75Inventor score
Top patents by PatentIndex Score
11 records- 0181US11473088B2Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock downUNIV OHIO·Filed 2017·Granted Oct 18, 2022·1 cites·23 claims
- 0278US12251421B2Methods for treating cancers using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2024·Granted Mar 18, 2025·0 cites·12 claims
- 0376US11975044B2Methods for treating cancers using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2022·Granted May 7, 2024·0 cites·3 claims
- 0475US11820804B2Peptide-based inhibitors of growth hormone action and methods of use thereofUNIV OHIO·Filed 2022·Granted Nov 21, 2023·0 cites·17 claims
- 0570US2023002775A1Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock downUNIV OHIO·Filed 2022·Application pending·0 cites
- 0668US11426445B2Methods for treating cancers using fat specific protein 27 (FSP27) compositionsUNIV OHIO·Filed 2018·Granted Aug 30, 2022·0 cites·4 claims
- 0767US2025099550A1Methods for treating alzheimers disease and related dementias and aging using pegylated growth hormone receptor antagonistsMOLECULAR TECH LABORATORIES LLC·Filed 2024·Application pending·0 cites
- 0865US2024082362A1Growth hormone antagonist and anti-cancer composition combination therapyMOLECULAR TECH LABORATORIES LLC·Filed 2023·Application pending·0 cites
- 0960US11857602B2Growth hormone antagonist and anti-cancer composition combination therapyMOLECULAR TECH LABORATORIES LLC·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 1060US11524986B2Peptide-based inhibitors of growth hormone action and methods of use thereofUNIV OHIO·Filed 2019·Granted Dec 13, 2022·0 cites·17 claims
- 1147US11452763B2Therapeutic pegylated growth hormone antagonistsMOLECULAR TECH LABORATORIES LLC·Filed 2020·Granted Sep 27, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Reetobrata Basu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →